G7LCV1 AF NFT

Kunitz type trypsin inhibitor 106

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeihwkcm45f3nio3fkrpwgm6gjtcgsjogbens4dhhqw3h7t266w3kji/metadata.json
IPFS of structure file: 
bafybeidjnfozoklpvi7gkwkcuw2ihj6fnbgxk6wuomn66g4higmzypuup4/AF-G7LCV1-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xE4E71404165cB399da9a1A055946405dE4aC9870
First NFT owner address (bech32): 
genesis1unn3gpqktjeenk56rgz4j3jqthj2exrsywe50l
Current NFT ID #203141 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
203141
Accession (UniProt):
G7LCV1
Name::
Kunitz type trypsin inhibitor 106
Experimental Method:
Predicted structure
Sequence source:
MEDICAGO TRUNCATULA

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT G7LCV1 research and analysis (ICN3D with VR)

FASTA sequences

>sp|G7LCV1|KI106_MEDTR Kunitz type trypsin inhibitor 106 OS=Medicago truncatula OX=3880 GN=KPI106 PE=1 SV=1 MSMRLSIRTLIILAHVCLFITTTTIAQFVLDTVGEPVEGDEEYFIRPVITNKGGRSTMVSRNESCPLHVGLELTGLGRGLVVKFTPFAPHHDFDDVRVNRDLRITFQASSSCVQSTEWRLGEKDTKSGRRLIITGTDSATNGSYGNFFRIVETPLEGMYNIQWCPTEVCPSCKFECGTVDMLNENGKILLALDGGPLPLVFQKE